| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.58B | 16.29B | 14.07B | 11.32B | 8.71B | 6.88B |
| Gross Profit | 11.30B | 12.83B | 10.83B | 8.99B | 7.29B | 5.79B |
| EBITDA | 2.58B | 3.09B | 2.41B | 1.83B | 1.36B | 1.36B |
| Net Income | 1.19B | 1.51B | 1.05B | 837.67M | 717.40M | 702.28M |
Balance Sheet | ||||||
| Total Assets | 11.28B | 13.38B | 11.30B | 10.16B | 4.41B | 3.81B |
| Cash, Cash Equivalents and Short-Term Investments | 3.94B | 5.20B | 4.17B | 3.47B | 1.65B | 1.68B |
| Total Debt | 2.37B | 2.73B | 2.49B | 2.75B | 0.00 | 0.00 |
| Total Liabilities | 5.52B | 6.17B | 5.86B | 6.01B | 1.24B | 1.41B |
| Stockholders Equity | 5.76B | 7.21B | 5.44B | 4.16B | 3.17B | 2.40B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.57B | 1.35B | 452.12M | -3.11M | 738.45M |
| Operating Cash Flow | 0.00 | 1.62B | 1.37B | 1.16B | 458.39M | 1.16B |
| Investing Cash Flow | 0.00 | -1.04B | -625.13M | -2.10B | -517.22M | -436.11M |
| Financing Cash Flow | 0.00 | 452.57M | -41.28M | 2.77B | 28.94M | -500.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥13.34B | 14.72 | ― | 2.91% | 6.19% | 28.57% | |
75 Outperform | ¥6.40B | 3.27 | ― | ― | 1.98% | 82.06% | |
72 Outperform | ¥4.30B | 18.65 | ― | 2.93% | 2.57% | ― | |
72 Outperform | ¥104.82B | 18.63 | ― | 3.44% | 6.52% | 74.47% | |
68 Neutral | ¥63.32B | 42.22 | ― | ― | 15.75% | 43.06% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | ¥1.82B | 23.80 | ― | ― | 19.02% | 15.39% |